NYSE American - Delayed Quote USD
Catheter Precision, Inc. (VTAK)
At close: October 25 at 3:59 PM EDT
After hours: October 25 at 7:59 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
436.0000
442.0000
14.0000
22.0000
259.0000
--
Cost of Revenue
34.0000
30.0000
161.0000
1,560.0000
2,172.0000
--
Gross Profit
402.0000
412.0000
-147.0000
-1,538.0000
-1,913.0000
--
Operating Expense
11,062.0000
17,597.0000
22,642.0000
27,728.0000
33,488.0000
--
Operating Income
-10,660.0000
-17,185.0000
-22,789.0000
-29,266.0000
-35,401.0000
--
Net Non Operating Interest Income Expense
191.0000
347.0000
--
--
21.0000
788.0000
Other Income Expense
978.0000
-53,734.0000
-4,073.0000
2,009.0000
88.0000
--
Pretax Income
-9,491.0000
-70,572.0000
-26,862.0000
-27,257.0000
-35,313.0000
--
Tax Provision
--
--
3.0000
4.0000
7.0000
--
Net Income Common Stockholders
-9,491.0000
-71,372.0000
-26,865.0000
-25,070.0000
-36,045.0000
--
Diluted NI Available to Com Stockholders
-9,491.0000
-71,372.0000
-26,865.0000
-25,070.0000
-36,045.0000
--
Basic EPS
1.48k
-129.90
-259.80
-2.48k
-10.61k
--
Diluted EPS
1.48k
-129.90
-259.80
-2.48k
-10.61k
--
Basic Average Shares
566.7500
549.5070
103.3820
10.1100
3.3980
--
Diluted Average Shares
566.7500
549.5070
103.3820
10.1100
3.3980
--
Total Operating Income as Reported
-10,660.0000
-78,119.0000
-26,961.0000
-29,266.0000
-35,401.0000
--
Total Expenses
11,096.0000
17,627.0000
22,803.0000
29,288.0000
35,660.0000
--
Net Income from Continuing & Discontinued Operation
-9,491.0000
-70,572.0000
-26,865.0000
-25,070.0000
-36,045.0000
--
Normalized Income
-9,491.0000
-9,638.0000
-23,569.1200
-28,737.7900
-35,320.0000
--
Interest Income
191.0000
347.0000
--
--
129.0000
1,038.0000
Interest Expense
--
--
--
--
108.0000
250.0000
Net Interest Income
191.0000
347.0000
--
--
21.0000
788.0000
EBIT
-10,660.0000
-17,185.0000
-22,789.0000
-29,266.0000
-35,401.0000
--
EBITDA
-8,575.0000
-15,110.0000
-22,368.0000
-27,701.0000
-33,036.0000
--
Reconciled Cost of Revenue
34.0000
30.0000
161.0000
1,560.0000
2,172.0000
--
Reconciled Depreciation
2,085.0000
2,075.0000
421.0000
1,565.0000
2,365.0000
--
Net Income from Continuing Operation Net Minority Interest
-9,491.0000
-70,572.0000
-26,865.0000
-27,261.0000
-35,320.0000
--
Total Unusual Items Excluding Goodwill
--
-60,934.0000
-4,172.0000
2,023.0000
--
--
Total Unusual Items
--
-60,934.0000
-4,172.0000
2,023.0000
--
--
Normalized EBITDA
-8,575.0000
45,824.0000
-18,196.0000
-29,724.0000
-33,036.0000
--
Tax Rate for Calcs
--
--
0.0002
0.0003
0.0003
--
Tax Effect of Unusual Items
--
--
-876.1200
546.2100
--
--
12/31/2019 - 9/27/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TNON Tenon Medical, Inc.
3.6200
-1.09%
BSGM BioSig Technologies, Inc.
0.8200
0.00%
NXL Nexalin Technology, Inc.
2.2900
+6.51%
BBLG Bone Biologics Corporation
1.7300
+0.58%
IRTC iRhythm Technologies, Inc.
75.68
-3.12%
NUWE Nuwellis, Inc.
1.8600
+13.41%
BJDX Bluejay Diagnostics, Inc.
0.1053
+5.83%
DXCM DexCom, Inc.
73.44
-1.88%
NAYA NAYA Biosciences, Inc.
0.8385
-4.72%
VERO Venus Concept Inc.
0.4580
-4.38%